- Reference code :
- wf5400
- Published date :
-
31 July 2008
- Expired date :
-
17 December 2035
During the first half of 2008, AstraZeneca has made good progress on three fronts: performance, pipeline and patents. The business is on track to achieve its increased financial target for the year and continues to strengthen the pipeline.
AstraZeneca PLC Second Quarter and Half Year Results 2008
Download the Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
